Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorUniversity Hospital, Toulouse

About this trial

This project aims to measure the effect of a semantic rehabilitation protocol for patients with primary progressive semantic aphasia and using the SCED methodology.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Have a diagnosis of primary progressive semantic aphasia according to the criteria of Gorno-Tempini et al (2011) (Appendix A)

Being in the mild to moderate stage of dementia (MMSE score between 10 and 28) (Crum et al., 1993; Derouesné et al., 1999)

Common French

Being affiliated to a social security scheme

Disqualifiers

Have significant uncorrected visual and/or hearing impairment

Have a history of brain injuries, major head trauma

Have untreated psychiatric disorders

Have significant motor and/or comprehension problems that make it impossible to take part in the study

Trial design

Design model

Parallel

Treatments tested in this trial

  • semantic therapy and semantic re-education

    Behavioral

    Patients will be followed over two periods "Phase A (randomized, 6 to 8 weeks) - Phase B (5 weeks)". Phase A : Baseline Phase A, which constitutes the control period of semantic therapy, will be composed of lexico-phonological training exercises (Piroux-Davous, 2018). This phase will last 6 to 8 weeks (i.e. 18 to 24 sessions) depending on the randomisation, at the rate of 3 speech therapy sessions of 45 minutes per week. Phase B : Semantic re-education The sessions will consist of training based on the analysis of semantic traits (Coustaut, 2019). This phase will last 5 weeks (i.e. 15 sessions), at the rate of 3 speech therapy sessions of 45 minutes per week. In accordance with the application of the SCED methodology, repeated measurements will be carried out every second session during phases A and B. They will consist of proposing the oral naming task (lasting 10 minutes).

Treatment groups

15 Participants
are divided into 2 treatment groups
Group A: 6 weeks phase AOther 1 intervention
Group B: 8 weeks phase AOther 1 intervention

Trial outcomes

Primary outcomes

1

Performance in speaking

To evaluate speaking accuracy, the study team will assess the number of correct items recovered by the patient when performing a specific naming task before the rehabilitation. The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol.

Time frame
Baseline (before phase A)
2

Performance in speaking

To evaluate speaking response time, the study team will assess the rate at which items are recovered by the patient when performing a specific naming task before the rehabilitation. The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol.

Time frame
Baseline (before phase A)
3

Performance in speaking

To evaluate speaking accuracy, the study team will assess the number of correct items repeated by the patient when performing a specific naming task after the rehabilitation. The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol.

Time frame
immediately after the intervention (after phase B)
4

Performance in speaking

To evaluate speaking response time, the study team will assess the rate at which items are recovered by the patient when performing a specific naming task after rehabilitation. The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol.

Time frame
immediately after the intervention (after phase B)

Secondary outcomes

1

Maintenance of the performance in speaking

Number of correct items recovered by the patient when performing a specific naming task 1 month after the end of the intervention. The naming task is a selection of 80 items developped by Coustaut in 2019 in its MetaLex protocol. This will be compared to the number of items correctly recovered at the end of the rehabilitation (corresponding to outcome 3 here).

Time frame
1 month after the end of the intervention (after phase B)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.